Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin plus 5-fluorouracil in recurrent ovarian carcinoma
2007-005289-11Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Aug 2008
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of oxaliplatin and fluorouracil in ovarian cancer (2 cohorts), sponsored by Institut Jules Bordet. Primary endpoint: Objective response rate. Started Aug 2008; status: completed.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2007-005289-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005289-11.